CELC

Celcuity Inc
10.51
0.155 (1.5%)

Period:

Draw Mode:

Volume 69,949
Bid Price 10.51
Ask Price 10.76
News (2)
Day High 10.86

Low
4.81

52 Week Range

High
14.402

Day Low 10.16
Company Name Stock Ticker Symbol Market Type
Celcuity Inc CELC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.155 1.5% 10.51 11:51:11
Open Price Low Price High Price Close Price Prev Close
10.31 10.16 10.86 10.355
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,327 69,949 $ 10.50 $ 734,693 - 4.81 - 14.402
Last Trade Time Type Quantity Stock Price Currency
11:51:11 52 $ 10.51 USD

Celcuity Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 227.96M 21.69M 17.31M $ - $ - -2.64 -4.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 177.79k 20.30%

more financials information »

Celcuity News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CELC Message Board. Create One! See More Posts on CELC Message Board See More Message Board Posts

Historical CELC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.9711.009.1210.25106,2670.545.42%
1 Month11.5911.8559.1210.50103,875-1.08-9.32%
3 Months10.8212.589.0810.6565,664-0.31-2.87%
6 Months9.4314.4027.5010.7147,0401.0811.45%
1 Year8.7014.4024.819.1661,5871.8120.8%
3 Years6.5033.014.0317.6776,5734.0161.69%
5 Years16.4333.014.0317.8551,118-5.92-36.03%

Celcuity Description

Celcuity Inc is a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications. The company's therapeutic candidate is gedatolisib, a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all Class I isoforms of PI3K and the mammalian target of rapamycin (mTOR).